BARCLAYS PLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$12,696
+25.3%
481,440
-18.3%
0.01%
+33.3%
Q2 2023$10,134
-9.2%
589,164
-12.5%
0.01%
+20.0%
Q1 2023$11,159
+21.8%
672,979
-44.0%
0.01%
+25.0%
Q4 2022$9,159
-99.7%
1,201,885
+268.2%
0.00%0.0%
Q3 2022$3,244,000
+1110.4%
326,417
+1008.8%
0.00%
Q2 2022$268,000
-38.0%
29,438
-30.9%
0.00%
Q1 2022$432,000
-93.3%
42,586
-89.0%
0.00%
-100.0%
Q4 2021$6,474,000
+54.3%
388,148
+333.4%
0.00%
-50.0%
Q3 2021$4,197,000
+9.2%
89,566
+42.1%
0.00%0.0%
Q2 2021$3,842,000
-37.8%
63,020
-37.1%
0.00%
-33.3%
Q1 2021$6,174,000
+138.2%
100,219
+175.0%
0.00%
+200.0%
Q4 2020$2,592,000
+107.0%
36,448
+9.2%
0.00%0.0%
Q3 2020$1,252,000
-15.6%
33,372
-26.6%
0.00%0.0%
Q2 2020$1,484,000
+74.4%
45,488
+54.9%
0.00%0.0%
Q1 2020$851,000
-7.1%
29,364
+12.4%
0.00%0.0%
Q4 2019$916,000
+211.6%
26,134
+90.7%
0.00%
Q3 2019$294,000
-37.0%
13,703
-20.9%
0.00%
Q2 2019$467,00017,3340.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders